help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gershengorn, M. C.
Right arrow Articles by Robbins, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gershengorn, M. C.
Right arrow Articles by Robbins, J.

Journal of Clinical Endocrinology & Metabolism, Vol 42, 105-111, Copyright © 1976 by Endocrine Society


ARTICLES

Use of lithium as an adjunct to radioiodine therapy of thyroid carcinoma

MC Gershengorn, M Izumi and J Robbins

The effect of lithium on iodine kinetics after oral 131I-iodide was studied in an athyreotic patient with follicular thyroid carcinoma. Lithium decreased the disappearance rate of 131I from the whole body and from a tumor mass in the patient's thigh from control values of 0.126/day, respectively, while having only a minimal effect on the rate of 131I disappearance from blood. The increased tumor 131I retention would be expected to increase the therapeutic:toxic ratio of 131I. However, a subsequent therapeutic dose of 131I-iodide given with lithium was accompanied by an unanticipated increase in blood 131I and, therefore, in whole body radiation, resulting in significant bone marrow depression. Although lithium may be a useful adjunct in 131I therapy of functional thyroid carcinoma, it must be used cautiously in future studies.


This article has been cited by other articles:


Home page
JNMHome page
U. Haberkorn, P. Beuter, W. Kubler, H. Eskerski, M. Eisenhut, R. Kinscherf, S. Zitzmann, L. G. Strauss, A. Dimitrakopoulou-Strauss, and A. Altmann
Iodide Kinetics and Dosimetry In Vivo After Transfer of the Human Sodium Iodide Symporter Gene in Rat Thyroid Carcinoma Cells
J. Nucl. Med., May 1, 2004; 45(5): 827 - 833.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
Y. Nakamoto, T. Saga, T. Misaki, H. Kobayashi, N. Sato, T. Ishimori, S. Kosugi, H. Sakahara, and J. Konishi
Establishment and Characterization of a Breast Cancer Cell Line Expressing Na+/I- Symporters for Radioiodide Concentrator Gene Therapy
J. Nucl. Med., November 1, 2000; 41(11): 1898 - 1904.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Rotman-Pikielny, J. C. Reynolds, W. C. Barker, P. M. Yen, M. C. Skarulis, and N. J. Sarlis
Recombinant Human Thyrotropin for the Diagnosis and Treatment of a Highly Functional Metastatic Struma Ovarii
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 237 - 244.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S.-S. Koong, J. C. Reynolds, E. G. Movius, A. M. Keenan, K. B. Ain, M. C. Lakshmanan, and J. Robbins
Lithium as a Potential Adjuvant to 131I Therapy of Metastatic, Well Differentiated Thyroid Carcinoma
J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 912 - 916.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Bogazzi, L. Bartalena, S. Brogioni, G. Scarcello, A. Burelli, A. Campomori, L. Manetti, G. Rossi, A. Pinchera, and E. Martino
Comparison of Radioiodine with Radioiodine plus Lithium in the Treatment of Graves' Hyperthyroidism
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 499 - 503.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1976 by The Endocrine Society